Literature DB >> 1492119

AIDS acquired by drug consumption and other noncontagious risk factors.

P H Duesberg1.   

Abstract

The hypothesis that human immunodeficiency virus (HIV) is a new, sexually transmitted virus that causes AIDS has been entirely unproductive in terms of public health benefits. Moreover, it fails to predict the epidemiology of AIDS, the annual AIDS risk and the very heterogeneous AIDS diseases of infected persons. The correct hypothesis must explain why: (1) AIDS includes 25 previously known diseases and two clinically and epidemiologically very different epidemics, one in America and Europe, the other in Africa; (2) almost all American (90%) and European (86%) AIDS patients are males over the age of 20, while African AIDS affects both sexes equally; (3) the annual AIDS risks of infected babies, intravenous drug users, homosexuals who use aphrodisiacs, hemophiliacs and Africans vary over 100-fold; (4) many AIDS patients have diseases that do not depend on immunodeficiency, such as Kaposi's sarcoma, lymphoma, dementia and wasting; (5) the AIDS diseases of Americans (97%) and Europeans (87%) are predetermined by prior health risks, including long-term consumption of illicit recreational drugs, the antiviral drug AZT and congenital deficiencies like hemophilia, and those of Africans are Africa-specific. Both negative and positive evidence shows that AIDS is not infectious: (1) the virus hypothesis fails all conventional criteria of causation; (2) over 100-fold different AIDS risks in different risk groups show that HIV is not sufficient for AIDS; (3) AIDS is only 'acquired,' if at all, years after HIV is neutralized by antibodies; (4) AIDS is new but HIV is a long-established, perinatally transmitted retrovirus; (5) alternative explanations disprove all assumptions and anecdotal cases cited in support of the virus hypothesis; (6) all AIDS-defining diseases occur in matched risk groups, at the same rate, in the absence of HIV; (7) there is no common, active microbe in all AIDS patients; (8) AIDS manifests in unpredictable and unrelated diseases; and (9) it does not spread randomly between the sexes in America and Europe. Based on numerous data documenting that drugs are necessary for HIV-positives and sufficient for HIV-negatives to develop AIDS diseases, it is proposed that all American/European AIDS diseases, that exceed their normal background, result from recreational and anti-HIV drugs. African AIDS is proposed to result from protein malnutrition, poor sanitation and subsequent parasitic infections. This hypothesis resolves all paradoxes of the virus-AIDS hypothesis. It is epidemiologically and experimentally testable and provides a rational basis for AIDS control.

Entities:  

Mesh:

Year:  1992        PMID: 1492119     DOI: 10.1016/0163-7258(92)90052-2

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  14 in total

Review 1.  Alternative models of the AIDS epidemic.

Authors:  H Caton
Journal:  Health Care Anal       Date:  1994-11

2.  AIDS in Africa: distinguishing fact and fiction.

Authors:  E Papadopulos-Eleopulos; V F Turner; J M Papadimitriou; H Bialy
Journal:  World J Microbiol Biotechnol       Date:  1995-03       Impact factor: 3.312

Review 3.  Critical analysis of the current views on the nature of AIDS.

Authors:  V L Koliadin
Journal:  Genetica       Date:  1995       Impact factor: 1.082

4.  The chemical bases of the various AIDS epidemics: recreational drugs, anti-viral chemotherapy and malnutrition.

Authors:  Peter Duesberg; Claus Koehnlein; David Rasnick
Journal:  J Biosci       Date:  2003-06       Impact factor: 1.826

5.  Professional responsibilities of biomedical scientists in public discourse.

Authors:  U Schüklenk
Journal:  J Med Ethics       Date:  2004-02       Impact factor: 2.903

Review 6.  Factor VIII, HIV and AIDS in haemophiliacs: an analysis of their relationship.

Authors:  E Papadopulos-Eleopulos; V F Turner; J M Papadimitriou; D Causer
Journal:  Genetica       Date:  1995       Impact factor: 1.082

Review 7.  Autoimmunity and dysmetabolism of human acquired immunodeficiency syndrome.

Authors:  Yan-Mei Huang; Xue-Zhi Hong; Jia-Hua Xu; Jiang-Xi Luo; Han-You Mo; Hai-Lu Zhao
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

8.  The toxicity of azidothymidine (AZT) on human and animal cells in culture at concentrations used for antiviral therapy.

Authors:  D T Chiu; P H Duesberg
Journal:  Genetica       Date:  1995       Impact factor: 1.082

Review 9.  A critical analysis of the HIV-T4-cell-AIDS hypothesis.

Authors:  E Papadopulos-Eleopulos; V F Turner; J M Papadimitriou; D Causer; B Hedland-Thomas; B A Page
Journal:  Genetica       Date:  1995       Impact factor: 1.082

10.  HIV as a surrogate marker for drug use: a re-analysis of the San Francisco Men's Health Study.

Authors:  B J Ellison; A B Downey; P H Duesberg
Journal:  Genetica       Date:  1995       Impact factor: 1.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.